Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Joe
Contact Joe, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
EMA director says smarter regulation can lead to lower drug prices
European Medicines Agency executive director Guido Rasi on Wednesday stated that a smarter and faster pharmaceutical approval system will be necessary to control rising pharmaceutical prices. Specifically, Rasi indicated that society would expect drugmakers to reduce drug prices if the approval process is hastened.
Sanofi names Bayer's Olivier Brandicourt as new CEO
Sanofi on Thursday announced that its board of directors unanimously appointed Olivier Brandicourt as its new CEO. Brandicourt, who has been chairman and CEO of Bayer's healthcare division since November 2013, will assume the new position effective April 2.
FDA advisory panel backs Johnson & Johnson, Medivir's hepatitis C drug simeprevir
An FDA advisory panel voted 19-0 to recommend approval of Johnson & Johnson and Medivir's experimental hepatitis C drug simeprevir. The vote follows a review released by agency staff earlier this week that found the once-daily oral protease inhibitor was "generally safe" and effective for most patients infected with hepatitis C virus (HCV).
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joe
Contact Joe, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack